Annals of the Rheumatic Diseases, ‎0003-4967

Journal

1 - 50 out of 164Page size: 50

Publications

  1. 2021
  2. Accepted/In press

    EULAR points to consider for conducting clinical trials and observational studies in individuals at-risk of rheumatoid arthritis

    Karim Raza, , , , & , 24 Jul 2021, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

    Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, , Gareth Lavery, Karim Raza & Rowan Hardy, Feb 2021, In: Annals of the Rheumatic Diseases. 80, 2, p. 250-260 11 p.

    Research output: Contribution to journal › Article › peer-review

  4. 2020
  5. Published

    Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

    Caroline Gordon, 25 Jun 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  6. Published

    PERSPECTIVES ON APPROACHES TO PREDICT THE DEVELOPMENT OF RHEUMATOID ARTHRITIS: A QUANTITATIVE ASSESSMENT OF PATIENTS AND THEIR FIRST DEGREE RELATIVES

    Gwenda Simons, , , Peter Nightingale, Karim Raza & M Falahee, 2 Jun 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Abstract › peer-review

  7. Published

    PREDICTING RHEUMATOID ARTHRITIS USING THE SYMPTOMS IN PERSONS AT RISK OF RHEUMATOID ARTHRITIS (SPARRA) QUESTIONNAIRE

    M Falahee, , , , Karim Raza & , 2 Jun 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Abstract › peer-review

  8. Published

    SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data

    2 Jun 2020, In: Annals of the Rheumatic Diseases. 79, Suppl 1, p. 1034-1035 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  9. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

    Caroline Gordon & 14 others, , , , , , , , , , , , , & , Mar 2020, In: Annals of the Rheumatic Diseases. 79, 3, p. 356-362 7 p.

    Research output: Contribution to journal › Article › peer-review

  11. Accepted/In press

    Disruptive Innovation in Rheumatology; New Networks of Global Public-Private Partnerships are Needed to Take Advantage of Scientific Progress

    Christopher Buckley, 26 Feb 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases. 79, 5

    Research output: Contribution to journal › Article › peer-review

  12. Published

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, , , , , , , Sue Jowett, , , , , , , & , Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

    Benjamin Fisher & 2 others, Simon Bowman & , Jan 2020, In: Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.

    Research output: Contribution to journal › Article › peer-review

  14. 2019
  15. Published

    Urine metabolic profile in rheumatoid arthritis development

    Stephen Young & , 27 Jun 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  16. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journal › Review article › peer-review

  17. Published

    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

    Lorraine Harper & , Mar 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 399-405

    Research output: Contribution to journal › Article › peer-review

  18. Published

    Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data

    Anuradhaa Subramanian, Nicola Adderley, , , , Lorraine Harper & Krishnarajah Nirantharakumar, Feb 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 261-269 9 p.

    Research output: Contribution to journal › Article › peer-review

  19. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, , & , 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome

    Saba Nayar, Joana Campos, , , David Gardner, , , , , , Christopher Buckley, Simon Bowman, , , , , Benjamin Fisher, , & Francesca Barone, 10 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 249-260 12 p.

    Research output: Contribution to journal › Article › peer-review

  21. 2018
  22. Published

    Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multinational SLE inception cohort

    Caroline Gordon, 20 Dec 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  23. E-pub ahead of print

    Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

    Jennifer Marshall, , , , , Ilfita Sahbudin, , , , , , Karim Raza, Andrew Filer, Christopher Buckley, & , 14 Dec 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  24. E-pub ahead of print

    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis

    Adam Croft, , , , , , , Christopher Buckley, , , & , 30 Jul 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  25. Published

    EARLY HELP SEEKING OR SELF-MANAGEMENT: A QUANTITATIVE ASSESSMENT IN THE CONTEXT OF RHEUMATOID ARTHRITIS

    Gwenda Simons, , Kanta Kumar, M Falahee, , & Karim Raza, 12 Jun 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Abstract › peer-review

  26. E-pub ahead of print

    Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?

    Benjamin Fisher, , , & Simon Bowman, 13 Apr 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  27. Published

    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

    Karim Raza, 12 Mar 2018, In: Annals of the Rheumatic Diseases. 77, p. 476-479

    Research output: Contribution to journal › Article › peer-review

  28. Published

    Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy

    Benjamin Fisher & Simon Bowman, 12 Feb 2018, In: Annals of the Rheumatic Diseases. 77, 3, p. 412-416

    Research output: Contribution to journal › Article › peer-review

  29. E-pub ahead of print

    High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk of subsequent rheumatoid arthritis in a Southern European nested case-control study.

    Paola De Pablo, , , , , , , , , , , , , , , , & Benjamin Fisher, 7 Feb 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  30. 2017
  31. Published

    Identification of a transitional fibroblast functional phenotype in very early rheumatoid arthritis

    Andrew Filer, , Sam Kemble, , , , Karim Raza, Christopher Buckley, Gerard Nash & Helen McGettrick, 13 Nov 2017, In: Annals of the Rheumatic Diseases. 76, 12, p. 2105-2112

    Research output: Contribution to journal › Article › peer-review

  32. E-pub ahead of print

    Antibodies against collagen type II are not a general marker of acute arthritis onset

    Andrew Filer, Karim Raza & , 24 Aug 2017, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  33. Published

    Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome

    Jul 2017, In: Annals of the Rheumatic Diseases. 76, 7, p. 1161-1168 8 p.

    Research output: Contribution to journal › Article › peer-review

  34. Published

    SAT0719-HPR ''and suddenly you are a person at risk of developing rheumatoid arthritis!’' Different perspectives of individuals on predictive testing –: results of an international qualitative interview study.

    Karim Raza, Rebecca Stack, Gwenda Simons, M Falahee, , , , & , 15 Jun 2017, In: Annals of the Rheumatic Diseases. 76, p. 1511

    Research output: Contribution to journal › Abstract › peer-review

  35. Published

    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Christopher Buckley, 17 Mar 2017, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  36. Published

    A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Caroline Gordon, 1 Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 554-561 8 p.

    Research output: Contribution to journal › Article › peer-review

  37. Published

    EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

    Karim Raza, 1 Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 491-496 6 p.

    Research output: Contribution to journal › Article › peer-review

  38. Published

    Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression

    Amy Naylor, John O'Neil, , Michael Ridley, , Timothy Smallie, Tina Tang, Jason Turner, , , , , , , Andrew Filer, Christopher Buckley, & Andrew R. Clark, Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 612-619

    Research output: Contribution to journal › Article › peer-review

  39. 2016
  40. E-pub ahead of print

    2016 update of the EULAR recommendations for the management of early arthritis

    Karim Raza, 15 Dec 2016, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  41. Published

    THU0061 Patients' Perceptions of Risk, Risk Communication and Predictive Testing for Rheumatoid Arthritis

    M Falahee, Gwenda Simons, & Karim Raza, 15 Jul 2016, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Abstract › peer-review

  42. Published

    MICL controls inflammation in rheumatoid arthritis

    Rebecca Drummond, , , , , , , , , , , , , & , 1 Jul 2016, In: Annals of the Rheumatic Diseases. 75, 7, p. 1386-1391 6 p.

    Research output: Contribution to journal › Article › peer-review

  43. Published

    Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis

    Maria Juarez, , , , Bernard Dyke, Ilfita Sahbudin, Christopher Buckley, Benjamin Fisher, Andrew Filer & Karim Raza, Jun 2016, In: Annals of the Rheumatic Diseases. 75, 6, p. 1099-1107 9 p.

    Research output: Contribution to journal › Article › peer-review

  44. Published

    Towards standardisation of histopathological assessments of germinal centres and lymphoid structures in primary Sjögren's syndrome

    Francesca Barone, & , Jun 2016, In: Annals of the Rheumatic Diseases. 75, 6, p. e31

    Research output: Contribution to journal › Article › peer-review

  45. Published

    Symptom recognition and its effect on help-seeking in rheumatoid arthritis, bowel cancer and angina: a mixed methods approach

    Gwenda Simons, , , Kanta Kumar, M Falahee, , Rebecca Stack & Karim Raza, 2016, In: Annals of the Rheumatic Diseases. 45, Suppl2, p. 455 1 p.

    Research output: Contribution to journal › Abstract › peer-review

  46. 2015
  47. Published

    Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

    Caroline Gordon, , , & , Nov 2015, In: Annals of the Rheumatic Diseases. 74, 11, p. 2006-2015 10 p.

    Research output: Contribution to journal › Article › peer-review

  48. Published

    A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker

    Benjamin Fisher, , Simon Bowman & Francesca Barone, Sep 2015, In: Annals of the Rheumatic Diseases. 74, 9, p. 1645-50 6 p.

    Research output: Contribution to journal › Article › peer-review

  49. Published

    Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

    Matthew Morgan, , Caroline Savage, , , , , , & , Jun 2015, In: Annals of the Rheumatic Diseases. 74, 6, p. 1178-82 5 p.

    Research output: Contribution to journal › Article › peer-review

  50. Published

    The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?

    Karim Raza & Andrew Filer, 1 May 2015, In: Annals of the Rheumatic Diseases. 74, 5, p. 793-794

    Research output: Contribution to journal › Editorial › peer-review

  51. Published

    Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis

    Lorraine Yeo, , , Maria Juarez, Timothy Smallie, , Christopher Buckley, Karim Raza, Andrew Filer & Dagmar Scheel-Toellner, 9 Apr 2015, In: Annals of the Rheumatic Diseases. 75, p. 763-771

    Research output: Contribution to journal › Article › peer-review

  52. Published

    Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials

    Lorraine Harper, , , , & , Jan 2015, In: Annals of the Rheumatic Diseases. 74, 1, p. 177-84 8 p.

    Research output: Contribution to journal › Article › peer-review

  53. Published

    Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis

    Andrew Filer, Christopher Buckley, , & , 2015, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  54. Published

    The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals

    Rachel Bayley, , Helen McGettrick, Jacqueline Smith, , Christopher Buckley & Stephen Young, 2015, In: Annals of the Rheumatic Diseases. 74, 8, p. 1588-95

    Research output: Contribution to journal › Article › peer-review

  55. 2014
  56. Published

    Response to: 'The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides' by Brink et al

    Paola De Pablo, Thomas Dietrich, Iain Chapple, Michael Milward, Christopher Buckley, & , Jul 2014, In: Annals of the Rheumatic Diseases. 73, 7, e47.

    Research output: Contribution to journal › Comment/debate › peer-review

  57. Published

    Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

    Christopher Buckley, & , Jun 2014, In: Annals of the Rheumatic Diseases. 73, 6, p. 1202-1210 9 p.

    Research output: Contribution to journal › Article › peer-review

  58. Published

    Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Caroline Gordon & 20 others, , , , , , , , , , , , , , , , , , , & , 16 May 2014, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 Next